WuXi AppTec Co., Ltd.
Follow13F filer, CIK 1832424, Shanghai, China
WuXi AppTec Co., Ltd. reported $23,330,789 across 2 holdings for the quarter ended 2024-06-30, in a 13F-HR filed 2024-08-06.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-24-086285
- Period
- 2024-06-30
- Reported value
- $23.3M
- Holdings
- 2
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 0
Largest buys vs the previous quarter
None.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| LYELL IMMUNOPHARMA INCreduced | -498,522 | -$723K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q2 2024
Share positions as resolved from 13F-HR 0001104659-24-086285, largest first. % of portfolio is the value over $23,330,789, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| ADAGADAGENE INC | 3,982,902 | $12.2M | 52.26% | 0 | Timeline | ||
| LYELL IMMUNOPHARMA INCLYELL IMMUNOPHARMA INC | 7,682,156 | $11.1M | 47.74% | -498,522 |
How Q2 2024 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001104659-24-086285 | base | 2024-08-06 | acceptance time not in the bulk data set |